Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic 2023-10-25 20:30
SEH Biotechnology: Revolutionizing the Global Beverage and Brewing Industry with Cutting-Edge Water and Biotech from Taiwan 2023-10-25 18:00
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons 2023-10-25 13:06
GC Cell Joins U.S Cancer Moonshot Project 2023-10-25 11:27
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development 2023-10-25 04:18
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma 2023-10-24 23:17
TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power 2023-10-24 22:31
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO 2023-10-24 21:00
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO 2023-10-24 20:00
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards 2023-10-24 12:00
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company 2023-10-24 12:00
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO 2023-10-24 08:41
LifeSpan Vision Ventures Invests in Matter Bio 2023-10-24 03:40
XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVICE CRO OPERATIONS TO GLOBAL RESEARCH INITIATIVES 2023-10-23 22:38
Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation 2023-10-23 22:00
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023 2023-10-23 21:48
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis 2023-10-23 21:30
Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC 2023-10-23 19:56
Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs 2023-10-23 18:25
1 73 74 75 76 77 451